
The UFC has suspended Manon Fiorot for three months after she tested positive for ostarine in connection with her bout against Alexa Grasso at Noche UFC. The promotion says its investigation linked the positive test to supplement contamination.
The UFC has handed Manon Fiorot a three-month suspension after she tested positive for ostarine in connection with her September fight against Alexa Grasso at Noche UFC. The promotion said its investigation traced the positive test to supplement contamination.
Fiorot, a 36-year-old French flyweight, is 13-3-0 and ranked third in the women's flyweight division. She trains out of Boxing Squad and fights from an orthodox stance. Her striking numbers are among the more productive in the division: she lands 5.57 significant strikes per minute at 40 percent accuracy. She does not chase submissions, averaging none per 15 minutes.

Grasso, 33, represents Mexico and sits one spot higher at number two in the flyweight rankings. She is 18-5-1, lands 4.19 significant strikes per minute at 41 percent accuracy, and averages 0.6 submission attempts per 15 minutes.
The two met on September 12 at Noche UFC: Silva vs. Delgado, and Grasso took a unanimous decision after three rounds. That is the only previous meeting between them in the record. It was also Fiorot's most recent recorded fight, and her second loss in her last three recorded bouts. Before it, she stopped Jasmine Jasudavicius with a first-round KO/TKO on October 18, 2025, and she lost a five-round unanimous decision to Valentina Shevchenko in a title fight at UFC 315 on May 10, 2025.

Why it matters
- Fiorot is sidelined at a point when she is coming off a loss to a higher-ranked rival, which leaves her path back to the top of the division to be worked out once the suspension ends.
- The suspension runs three months, a short layoff compared with many doping-related penalties, reflecting the UFC's finding that contamination was the source.
- Grasso's decision win stands as the result of the fight in the record, and she holds the number-two flyweight ranking.
Ostarine is a selective androgen receptor modulator, and the UFC's explanation points to a tainted supplement rather than deliberate use. The promotion's announcement did not change the outcome of the September bout as recorded.












